TBG Diagnostics Limited announced consolidated earnings results for the half year ended June 30, 2017. For the half year, the company reported revenue from continuing operations of AUD 1,762,020, loss before income tax expense was AUD 995,954, loss from continuing operations was AUD 995,954 or 0.46 cents per basic and diluted share, loss for the period was AUD 995,954 or 0.46 cents per basic and diluted share, net cash flows used in operating activities was AUD 798,328 and payments for plant and equipment was AUD 115,310.